Graybug Vision, Inc.
Graybug Vision, Inc. (GRAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRAY · as of Jun 9, 2026
Key Statistics
Explore Graybug Vision, Inc. Data
gray stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
The GRAY analyst consensus is Hold, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $27.83, representing +406.00% upside from the current price of $5.50.
Competitors & Peers
gray competitorsGRAY
ATYR
CYT
DBTX
KNTE
NGMStock Performance
Full HistoryAbout Graybug Vision, Inc.
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagshi…
what is graybug vision, inc. · gray stock overview · graybug vision, inc. company profile · who is graybug vision, inc. ceo · gray NASDAQ · graybug vision, inc. headquarters · graybug vision, inc. business segments
About Stock Overview & Key Data
Graybug Vision, Inc. (GRAY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 4, 2020. As of the latest trading session, GRAY stock price is $5.50, with a market capitalization of $121.0M. The stock has returned +366.10% over the past 12 months and +864.91% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Graybug Vision, Inc. stock is Hold, with an average 12-month price target of $27.83. In fiscal year 2025, Graybug Vision, Inc. reported revenue of — and net income of -$29.6M. For detailed data — including Graybug Vision, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Graybug Vision, Inc. (GRAY) stock price is $5.50. The stock is traded on NASDAQ under the ticker symbol GRAY. The 52-week range is $4.88 – $20.30.